+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Desflurane Market by End User (Ambulatory Surgical Centers, Clinics, Hospitals), Application (Cardiology, General Surgery, Obstetrics & Gynecology), Distribution Channel, Packaging Type - Global Forecast 2025-2030- Product Image
Desflurane Market by End User (Ambulatory Surgical Centers, Clinics, Hospitals), Application (Cardiology, General Surgery, Obstetrics & Gynecology), Distribution Channel, Packaging Type - Global Forecast 2025-2030- Product Image
New

Desflurane Market by End User (Ambulatory Surgical Centers, Clinics, Hospitals), Application (Cardiology, General Surgery, Obstetrics & Gynecology), Distribution Channel, Packaging Type - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 190 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6146138
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
Desflurane has emerged as a cornerstone in the delivery of modern inhalational anesthesia, distinguished by its rapid onset and offset characteristics that optimize operating room efficiency. This compound’s low blood-gas partition coefficient enables anesthesiologists to achieve precise control over sedation levels, reducing the risk of hemodynamic instability and accelerating patient recovery times. In addition, desflurane’s minimal metabolism by hepatic enzymes limits toxic byproduct accumulation, thereby enhancing patient safety during procedures of varying complexity.

Recent clinical evaluations have highlighted that desflurane’s pharmacokinetic profile aligns with the evolving demands of ambulatory and high-throughput surgical settings. Its ability to facilitate swift emergence from anesthesia supports same-day discharge protocols, contributing to reduced hospital stay durations and lower overall healthcare costs. Moreover, environmental considerations have prompted interest in desflurane’s greenhouse gas profile relative to other volatile agents, stimulating research into containment and scavenging systems aimed at minimizing atmospheric release. As regulatory bodies increasingly scrutinize the ecological footprint of anesthetic gases, desflurane’s role is being reexamined through the lenses of both clinical efficacy and sustainability.

Analyzing the Transformative Shifts in Anesthesia Practice Driven by Technological Innovations and Regulatory Dynamics Impacting Desflurane Usage

The anesthesia landscape is undergoing transformative shifts driven by technological innovations, evolving safety standards, and heightened environmental scrutiny. Advancements in vaporizer design now enable more precise control of desflurane delivery, integrating digital monitoring and closed-loop feedback systems that enhance dosage accuracy and reduce agent wastage. These improvements synergize with real-time analytics platforms, empowering clinicians to adapt anesthetic depth dynamically and improve patient outcomes.

Concurrently, regulatory frameworks are tightening around occupational exposure and environmental emissions. Mandates for lower permissible exposure limits have accelerated adoption of scavenging technologies designed to capture excess desflurane at the point of use. On the clinical front, the emphasis on value-based care has intensified scrutiny of perioperative efficiency, prompting hospitals to evaluate inhalational agents not only on efficacy but also on their impact on turnover times and resource utilization. In parallel, investment in staff training programs underscores the importance of standardized protocols for administration and emergency intervention. Taken together, these shifts illustrate a landscape in which technological, regulatory, and operational factors converge to redefine how desflurane is deployed within modern healthcare ecosystems.

Assessing the Cumulative Impact of United States Tariff Adjustments in 2025 on Desflurane Supply Chains and Anesthesia Service Delivery Models

In 2025, adjustments to United States trade tariffs have created reverberations throughout the desflurane supply chain, altering procurement strategies and cost structures for healthcare providers. Import duties on raw materials and finished vials have prompted manufacturers to reassess sourcing models, leading some to diversify production across multiple geographies. This strategic realignment aims to mitigate supply disruptions and shield end users from unanticipated price fluctuations, ensuring continuous availability in critical care settings.

Hospitals and surgical centers are responding by forging strategic partnerships with domestic manufacturers capable of providing just-in-time inventory solutions. These collaborations are encouraging investments in localized packaging lines and buffer stocks, enabling more predictable order fulfillment. Simultaneously, anesthesia departments are reevaluating consumable budgets and exploring alternative cost-containment measures. For some facilities, increased tariff burdens have catalyzed the adoption of advanced gas recapture and recycling technologies, which can offset incremental costs by reducing overall agent consumption. By understanding the interplay between tariff policies and operational imperatives, stakeholders can develop resilient strategies that safeguard both clinical efficacy and financial sustainability.

Uncovering Strategic Segmentation Insights Spanning End User Settings Applications Distribution Channels and Packaging Preferences in Desflurane Markets

A nuanced understanding of market segmentation reveals distinct patterns in desflurane utilization across diverse care settings and clinical applications. End users encompass ambulatory surgical centers that operate as freestanding units or remain affiliated with hospitals, clinics that function in outpatient or specialty care environments, and hospitals that are organized under private or public ownership. Each setting exhibits unique throughput demands, staffing models, and capital investment capacities that influence procurement cycles and inventory management.

Clinical applications further differentiate usage profiles, spanning cardiology cases such as bypass surgery and valve replacement, general surgical procedures including laparoscopic and open approaches, obstetrics and gynecology interventions like cesarean sections and natural births, as well as orthopedic operations for joint replacements and spinal surgeries. Within the distribution network, drug wholesalers operate at national and regional scales, hospital pharmacies manage inpatient and outpatient dispensing, prescription-focused online pharmacies handle e-commerce orders, and retail pharmacies-both chain and independent-serve post-discharge requirements. Packaging preferences also play a critical role: multi dose vials available in 20 ml or 50 ml formats cater to high-volume settings, while single dose vials of 10 ml or 5 ml ensure dosing accuracy in lower throughput environments. Recognizing these segmentation layers empowers manufacturers and providers to tailor supply strategies, marketing initiatives, and service offerings with precision.

Revealing Critical Regional Insights Highlighting Diversity in Desflurane Adoption Trends across Americas Europe Middle East Africa and Asia Pacific Landscapes

Regional dynamics shape desflurane adoption in ways that reflect local healthcare infrastructures, regulatory frameworks, and economic considerations. In the Americas, a combination of public and private reimbursement models drives demand in both urban medical centers and community hospitals. Proactive environmental policies encourage the deployment of emission reduction technologies, while value-based care initiatives foster collaborative purchasing agreements that emphasize cost efficiency and clinical quality.

Across Europe, the Middle East, and Africa, disparate regulatory environments and varying levels of healthcare investment create a mosaic of market conditions. Western European nations often lead in the implementation of advanced monitoring and waste gas capture systems, whereas emerging markets focus on expanding surgical capacity and improving access to essential anesthetic agents. Middle Eastern healthcare networks are investing heavily in facility upgrades, positioning regional hubs as centers of medical tourism. In Africa, infrastructure constraints and supply chain complexities underscore the need for robust distribution partnerships and training programs.

In the Asia-Pacific region, rapid expansion of private hospital chains and ambulatory centers is fueling demand for inhalational anesthetics with favorable recovery profiles. Local manufacturing capabilities are on the rise, supported by government incentives and technology transfer agreements. These developments are complemented by growing interest in sustainable anesthesia practices, as stakeholders seek to balance clinical performance with ecological responsibility.

Highlighting Key Competitive Company Insights and Strategic Initiatives Driving Innovation Operational Excellence and Market Positioning in the Global Desflurane Sector

Leading companies in the desflurane sector are distinguishing themselves through innovation, strategic collaborations, and operational excellence. Industry incumbents are investing in research partnerships to optimize agent delivery systems, enhance safety features, and develop next-generation vaporizers with digital connectivity. Concurrently, alliances with environmental technology firms are driving the advancement of gas scavenging solutions designed to minimize occupational exposure and atmospheric emissions.

Meanwhile, new entrants and regional players are carving out market share by focusing on niche segments and localized support services. By offering flexible supply agreements, customized training modules, and rapid technical assistance, these companies are building brand loyalty among anesthesiology teams. In addition, strategic acquisitions and joint ventures are enabling established manufacturers to expand their geographic footprint and diversify their product portfolios. Collectively, these competitive maneuvers underscore the importance of aligning clinical value propositions with sustainability imperatives and service-oriented business models.

Delivering Actionable Recommendations for Industry Leaders to Optimize Desflurane Portfolio Strategies Enhance Operational Efficiency and Sustain Competitive Advantage

Industry leaders can capitalize on emerging opportunities by adopting a multi-faceted strategy that balances product innovation, operational resilience, and stakeholder engagement. Investing in next-generation vaporizer technologies equipped with real-time analytics capabilities will enhance dosing precision while reducing resource consumption. At the same time, diversifying manufacturing and packaging operations across multiple regions can mitigate risks associated with trade policy fluctuations and supply chain disruptions.

Engagement with healthcare providers through targeted training programs will foster protocol standardization and improve clinical outcomes. Establishing value-based purchasing partnerships that align reimbursement with performance metrics can further drive adoption of premium anesthetic solutions. Finally, integrating sustainability initiatives-such as gas capture systems and carbon offset programs-into corporate social responsibility frameworks will strengthen brand reputation and resonate with environmentally conscious decision-makers. By executing these recommendations, industry stakeholders can secure competitive advantage, optimize total cost of care, and support the long-term growth of the desflurane market.

Detailing a Comprehensive Research Methodology Emphasizing Rigorous Data Collection Analytical Frameworks and Stakeholder Engagement Protocols for Desflurane Analysis

This research employs a rigorous multi-phase methodology designed to ensure accuracy, relevance, and transparency. Secondary information was gathered from peer-reviewed journals, regulatory agency publications, and industry white papers to establish a foundational understanding of desflurane’s clinical applications, safety profile, and environmental considerations. These data were complemented by primary interviews with anesthesiologists, supply chain managers, and environmental health experts to capture qualitative insights and real-world perspectives.

Quantitative analyses involved the triangulation of import-export databases, procurement records, and facility-level consumption metrics to validate trends and identify regional variances. A structured framework was used to segment the market by end user, application, distribution channel, and packaging type. Data integrity was maintained through cross-verification, while thematic coding of interview responses provided a robust qualitative overlay. The resulting synthesis offers a comprehensive view of market dynamics, supported by clearly documented assumptions and methodological limitations.

Summarizing the Conclusion with Strategic Insights Synthesizing Market Dynamics Potential Challenges and Strategic Imperatives for Desflurane Stakeholders

In conclusion, desflurane continues to hold a strategic position in the anesthesia arsenal due to its favorable pharmacokinetic properties, operational efficiencies, and compatibility with contemporary surgical models. As technological innovations and regulatory pressures reshape the delivery and environmental footprint of inhalational agents, stakeholders must adopt adaptive strategies that integrate advanced vaporizer controls, supply chain diversification, and sustainability initiatives.

Understanding the nuances of market segmentation and regional variation is critical for manufacturers aiming to tailor offerings to specific clinical and distribution ecosystems. By leveraging detailed insights on tariff impacts, competitive activity, and end user preferences, decision-makers can optimize procurement, training, and investment decisions. Ultimately, staying ahead in the desflurane landscape requires a balanced approach that harmonizes clinical performance, economic considerations, and environmental stewardship.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • End User
    • Ambulatory Surgical Centers
      • Freestanding
      • Hospital Affiliated
    • Clinics
      • Outpatient Clinics
      • Specialty Clinics
    • Hospitals
      • Private
      • Public
  • Application
    • Cardiology
      • Bypass Surgery
      • Valve Replacement
    • General Surgery
      • Laparoscopic Surgery
      • Open Surgery
    • Obstetrics & Gynecology
      • Cesarean Section
      • Natural Birth
    • Orthopedics
      • Joint Replacement
      • Spinal Surgery
  • Distribution Channel
    • Drug Wholesalers
      • National Wholesalers
      • Regional Wholesalers
    • Hospital Pharmacies
      • Inpatient Pharmacy
      • Outpatient Pharmacy
    • Online Pharmacies
      • Prescription Pharmacies
    • Retail Pharmacies
      • Chain Pharmacies
      • Independent Pharmacies
  • Packaging Type
    • Multi Dose Vials
      • 20 Ml Vial
      • 50 Ml Vial
    • Single Dose Vials
      • 10 Ml Vial
      • 5 Ml Vial
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Baxter International, Inc.
  • Fresenius Kabi AG
  • Piramal Enterprises Limited
  • Hikma Pharmaceuticals PLC
  • Aspen Pharmacare Holdings Limited
  • Halocarbon Products Corporation
  • Jiangsu Nhwa Pharmaceutical Co., Ltd.
  • Shanghai Hengrui Pharmaceutical Co., Ltd.
  • Guangzhou Freda Pharmaceutical Co., Ltd.
  • Sichuan Kelun Pharmaceutical Co., Ltd.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Adoption of closed-circuit anesthesia systems to reduce desflurane consumption and environmental emissions
5.2. Rising investments in next-generation vaporizers optimized for low-flow desflurane delivery and safety monitoring
5.3. Regulatory scrutiny on desflurane usage due to high global warming potential driving shifts to sevoflurane alternatives
5.4. Technological integration of real-time gas monitoring and AI-driven analytics to enhance desflurane dosing efficiency
5.5. Expansion of desflurane manufacturing capacity in Asia Pacific to address rising surgical procedure volumes and pricing pressures
5.6. Collaborative research initiatives on advanced scavenging systems to capture and recycle desflurane from operating room emissions
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Desflurane Market, by End User
8.1. Introduction
8.2. Ambulatory Surgical Centers
8.2.1. Freestanding
8.2.2. Hospital Affiliated
8.3. Clinics
8.3.1. Outpatient Clinics
8.3.2. Specialty Clinics
8.4. Hospitals
8.4.1. Private
8.4.2. Public
9. Desflurane Market, by Application
9.1. Introduction
9.2. Cardiology
9.2.1. Bypass Surgery
9.2.2. Valve Replacement
9.3. General Surgery
9.3.1. Laparoscopic Surgery
9.3.2. Open Surgery
9.4. Obstetrics & Gynecology
9.4.1. Cesarean Section
9.4.2. Natural Birth
9.5. Orthopedics
9.5.1. Joint Replacement
9.5.2. Spinal Surgery
10. Desflurane Market, by Distribution Channel
10.1. Introduction
10.2. Drug Wholesalers
10.2.1. National Wholesalers
10.2.2. Regional Wholesalers
10.3. Hospital Pharmacies
10.3.1. Inpatient Pharmacy
10.3.2. Outpatient Pharmacy
10.4. Online Pharmacies
10.4.1. Prescription Pharmacies
10.5. Retail Pharmacies
10.5.1. Chain Pharmacies
10.5.2. Independent Pharmacies
11. Desflurane Market, by Packaging Type
11.1. Introduction
11.2. Multi Dose Vials
11.2.1. 20 Ml Vial
11.2.2. 50 Ml Vial
11.3. Single Dose Vials
11.3.1. 10 Ml Vial
11.3.2. 5 Ml Vial
12. Americas Desflurane Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Desflurane Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Desflurane Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Baxter International, Inc.
15.3.2. Fresenius Kabi AG
15.3.3. Piramal Enterprises Limited
15.3.4. Hikma Pharmaceuticals PLC
15.3.5. Aspen Pharmacare Holdings Limited
15.3.6. Halocarbon Products Corporation
15.3.7. Jiangsu Nhwa Pharmaceutical Co., Ltd.
15.3.8. Shanghai Hengrui Pharmaceutical Co., Ltd.
15.3.9. Guangzhou Freda Pharmaceutical Co., Ltd.
15.3.10. Sichuan Kelun Pharmaceutical Co., Ltd.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. DESFLURANE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL DESFLURANE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL DESFLURANE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL DESFLURANE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL DESFLURANE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 6. GLOBAL DESFLURANE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL DESFLURANE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL DESFLURANE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DESFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL DESFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DESFLURANE MARKET SIZE, BY PACKAGING TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL DESFLURANE MARKET SIZE, BY PACKAGING TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS DESFLURANE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS DESFLURANE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES DESFLURANE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES DESFLURANE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA DESFLURANE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DESFLURANE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC DESFLURANE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC DESFLURANE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. DESFLURANE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. DESFLURANE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. DESFLURANE MARKET: RESEARCHAI
FIGURE 24. DESFLURANE MARKET: RESEARCHSTATISTICS
FIGURE 25. DESFLURANE MARKET: RESEARCHCONTACTS
FIGURE 26. DESFLURANE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. DESFLURANE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL DESFLURANE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL DESFLURANE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL DESFLURANE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL DESFLURANE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL DESFLURANE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL DESFLURANE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL DESFLURANE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL DESFLURANE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL DESFLURANE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL DESFLURANE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL DESFLURANE MARKET SIZE, BY FREESTANDING, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL DESFLURANE MARKET SIZE, BY FREESTANDING, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL DESFLURANE MARKET SIZE, BY HOSPITAL AFFILIATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL DESFLURANE MARKET SIZE, BY HOSPITAL AFFILIATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL DESFLURANE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL DESFLURANE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL DESFLURANE MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL DESFLURANE MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL DESFLURANE MARKET SIZE, BY OUTPATIENT CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL DESFLURANE MARKET SIZE, BY OUTPATIENT CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL DESFLURANE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL DESFLURANE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL DESFLURANE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL DESFLURANE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL DESFLURANE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL DESFLURANE MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL DESFLURANE MARKET SIZE, BY PRIVATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL DESFLURANE MARKET SIZE, BY PRIVATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL DESFLURANE MARKET SIZE, BY PUBLIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL DESFLURANE MARKET SIZE, BY PUBLIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL DESFLURANE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL DESFLURANE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL DESFLURANE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL DESFLURANE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL DESFLURANE MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL DESFLURANE MARKET SIZE, BY CARDIOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL DESFLURANE MARKET SIZE, BY BYPASS SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL DESFLURANE MARKET SIZE, BY BYPASS SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL DESFLURANE MARKET SIZE, BY VALVE REPLACEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL DESFLURANE MARKET SIZE, BY VALVE REPLACEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL DESFLURANE MARKET SIZE, BY CARDIOLOGY, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL DESFLURANE MARKET SIZE, BY CARDIOLOGY, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL DESFLURANE MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL DESFLURANE MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL DESFLURANE MARKET SIZE, BY LAPAROSCOPIC SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL DESFLURANE MARKET SIZE, BY LAPAROSCOPIC SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL DESFLURANE MARKET SIZE, BY OPEN SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL DESFLURANE MARKET SIZE, BY OPEN SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL DESFLURANE MARKET SIZE, BY GENERAL SURGERY, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL DESFLURANE MARKET SIZE, BY GENERAL SURGERY, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL DESFLURANE MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL DESFLURANE MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL DESFLURANE MARKET SIZE, BY CESAREAN SECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL DESFLURANE MARKET SIZE, BY CESAREAN SECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL DESFLURANE MARKET SIZE, BY NATURAL BIRTH, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL DESFLURANE MARKET SIZE, BY NATURAL BIRTH, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL DESFLURANE MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL DESFLURANE MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL DESFLURANE MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL DESFLURANE MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL DESFLURANE MARKET SIZE, BY JOINT REPLACEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL DESFLURANE MARKET SIZE, BY JOINT REPLACEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL DESFLURANE MARKET SIZE, BY SPINAL SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL DESFLURANE MARKET SIZE, BY SPINAL SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL DESFLURANE MARKET SIZE, BY ORTHOPEDICS, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL DESFLURANE MARKET SIZE, BY ORTHOPEDICS, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL DESFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL DESFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL DESFLURANE MARKET SIZE, BY DRUG WHOLESALERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL DESFLURANE MARKET SIZE, BY DRUG WHOLESALERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL DESFLURANE MARKET SIZE, BY NATIONAL WHOLESALERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL DESFLURANE MARKET SIZE, BY NATIONAL WHOLESALERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL DESFLURANE MARKET SIZE, BY REGIONAL WHOLESALERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL DESFLURANE MARKET SIZE, BY REGIONAL WHOLESALERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL DESFLURANE MARKET SIZE, BY DRUG WHOLESALERS, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL DESFLURANE MARKET SIZE, BY DRUG WHOLESALERS, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL DESFLURANE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL DESFLURANE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL DESFLURANE MARKET SIZE, BY INPATIENT PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL DESFLURANE MARKET SIZE, BY INPATIENT PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL DESFLURANE MARKET SIZE, BY OUTPATIENT PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL DESFLURANE MARKET SIZE, BY OUTPATIENT PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL DESFLURANE MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL DESFLURANE MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL DESFLURANE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL DESFLURANE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL DESFLURANE MARKET SIZE, BY PRESCRIPTION PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL DESFLURANE MARKET SIZE, BY PRESCRIPTION PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL DESFLURANE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL DESFLURANE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL DESFLURANE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL DESFLURANE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL DESFLURANE MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL DESFLURANE MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL DESFLURANE MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL DESFLURANE MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL DESFLURANE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL DESFLURANE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL DESFLURANE MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL DESFLURANE MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL DESFLURANE MARKET SIZE, BY MULTI DOSE VIALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL DESFLURANE MARKET SIZE, BY MULTI DOSE VIALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL DESFLURANE MARKET SIZE, BY 20 ML VIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL DESFLURANE MARKET SIZE, BY 20 ML VIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL DESFLURANE MARKET SIZE, BY 50 ML VIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL DESFLURANE MARKET SIZE, BY 50 ML VIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL DESFLURANE MARKET SIZE, BY MULTI DOSE VIALS, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL DESFLURANE MARKET SIZE, BY MULTI DOSE VIALS, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL DESFLURANE MARKET SIZE, BY SINGLE DOSE VIALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL DESFLURANE MARKET SIZE, BY SINGLE DOSE VIALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL DESFLURANE MARKET SIZE, BY 10 ML VIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL DESFLURANE MARKET SIZE, BY 10 ML VIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL DESFLURANE MARKET SIZE, BY 5 ML VIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL DESFLURANE MARKET SIZE, BY 5 ML VIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL DESFLURANE MARKET SIZE, BY SINGLE DOSE VIALS, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL DESFLURANE MARKET SIZE, BY SINGLE DOSE VIALS, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS DESFLURANE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS DESFLURANE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS DESFLURANE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS DESFLURANE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS DESFLURANE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS DESFLURANE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS DESFLURANE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS DESFLURANE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS DESFLURANE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS DESFLURANE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS DESFLURANE MARKET SIZE, BY CARDIOLOGY, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS DESFLURANE MARKET SIZE, BY CARDIOLOGY, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS DESFLURANE MARKET SIZE, BY GENERAL SURGERY, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS DESFLURANE MARKET SIZE, BY GENERAL SURGERY, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS DESFLURANE MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS DESFLURANE MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS DESFLURANE MARKET SIZE, BY ORTHOPEDICS, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS DESFLURANE MARKET SIZE, BY ORTHOPEDICS, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS DESFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS DESFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS DESFLURANE MARKET SIZE, BY DRUG WHOLESALERS, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS DESFLURANE MARKET SIZE, BY DRUG WHOLESALERS, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS DESFLURANE MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS DESFLURANE MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS DESFLURANE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS DESFLURANE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS DESFLURANE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS DESFLURANE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS DESFLURANE MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS DESFLURANE MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS DESFLURANE MARKET SIZE, BY MULTI DOSE VIALS, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS DESFLURANE MARKET SIZE, BY MULTI DOSE VIALS, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS DESFLURANE MARKET SIZE, BY SINGLE DOSE VIALS, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS DESFLURANE MARKET SIZE, BY SINGLE DOSE VIALS, 2025-2030 (USD MILLION)
TABLE 153. AMERICAS DESFLURANE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 154. AMERICAS DESFLURANE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES DESFLURANE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES DESFLURANE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES DESFLURANE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES DESFLURANE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES DESFLURANE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES DESFLURANE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES DESFLURANE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES DESFLURANE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES DESFLURANE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES DESFLURANE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES DESFLURANE MARKET SIZE, BY CARDIOLOGY, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES DESFLURANE MARKET SIZE, BY CARDIOLOGY, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES DESFLURANE MARKET SIZE, BY GENERAL SURGERY, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES DESFLURANE MARKET SIZE, BY GENERAL SURGERY, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES DESFLURANE MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES DESFLURANE MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, 2025-2030 (USD MILLION)
TABLE 171. UNITED STATES DESFLURANE MARKET SIZE, BY ORTHOPEDICS, 2018-2024 (USD MILLION)
TABLE 172. UNITED STATES DESFLURANE MARKET SIZE, BY ORTHOPEDICS, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES DESFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES DESFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES DESFLURANE MARKET SIZE, BY DRUG WHOLESALERS, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES DESFLURANE MARKET SIZE, BY DRUG WHOLESALERS, 2025-2030 (USD MILLION)
TABLE 177. UNITED STATES DESFLURANE MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 178. UNITED STATES DESFLURANE MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES DESFLURANE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES DESFLURANE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES DESFLURANE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES DESFLURANE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 183. UNITED STATES DESFLURANE MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 184. UNITED STATES DESFLURANE MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 185. UNITED STATES DESFLURANE MARKET SIZE, BY MULTI DOSE VIALS, 2018-2024 (USD MILLION)
TABLE 186. UNITED STATES DESFLURANE MARKET SIZE, BY MULTI DOSE VIALS, 2025-2030 (USD MILLION)
TABLE 187. UNITED STATES DESFLURANE MARKET SIZE, BY SINGLE DOSE VIALS, 2018-2024 (USD MILLION)
TABLE 188. UNITED STATES DESFLURANE MARKET SIZE, BY SINGLE DOSE VIALS, 2025-2030 (USD MILLION)
TABLE 189. UNITED STATES DESFLURANE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 190. UNITED STATES DESFLURANE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 191. CANADA DESFLURANE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 192. CANADA DESFLURANE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 193. CANADA DESFLURANE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 194. CANADA DESFLURANE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 195. CANADA DESFLURANE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 196. CANADA DESFLURANE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 197. CANADA DESFLURANE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 198. CANADA DESFLURANE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 199. CANADA DESFLURANE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 200. CANADA DESFLURANE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 201. CANADA DESFLURANE MARKET SIZE, BY CARDIOLOGY, 2018-2024 (USD MILLION)
TABLE 202. CANADA DESFLURANE MARKET SIZE, BY CARDIOLOGY, 2025-2030 (USD MILLION)
TABLE 203. CANADA DESFLURANE MARKET SIZE, BY GENERAL SURGERY, 2018-2024 (USD MILLION)
TABLE 204. CANADA DESFLURANE MARKET SIZE, BY GENERAL SURGERY, 2025-2030 (USD MILLION)
TABLE 205. CANADA DESFLURANE MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, 2018-2024 (USD MILLION)
TABLE 206. CANADA DESFLURANE MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, 2025-2030 (USD MILLION)
TABLE 207. CANADA DESFLURANE MARKET SIZE, BY ORTHOPEDICS, 2018-2024 (USD MILLION)
TABLE 208. CANADA DESFLURANE MARKET SIZE, BY ORTHOPEDICS, 2025-2030 (USD MILLION)
TABLE 209. CANADA DESFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 210. CANADA DESFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 211. CANADA DESFLURANE MARKET SIZE, BY DRUG WHOLESALERS, 2018-2024 (USD MILLION)
TABLE 212. CANADA DESFLURANE MARKET SIZE, BY DRUG WHOLESALERS, 2025-2030 (USD MILLION)
TABLE 213. CANADA DESFLURANE MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 214. CANADA DESFLURANE MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 215. CANADA DESFLURANE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 216. CANADA DESFLURANE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 217. CANADA DESFLURANE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 218. CANADA DESFLURANE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 219. CANADA DESFLURANE MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 220. CANADA DESFLURANE MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 221. CANADA DESFLURANE MARKET SIZE, BY MULTI DOSE VIALS, 2018-2024 (USD MILLION)
TABLE 222. CANADA DESFLURANE MARKET SIZE, BY MULTI DOSE VIALS, 2025-2030 (USD MILLION)
TABLE 223. CANADA DESFLURANE MARKET SIZE, BY SINGLE DOSE VIALS, 2018-2024 (USD MILLION)
TABLE 224. CANADA DESFLURANE MARKET SIZE, BY SINGLE DOSE VIALS, 2025-2030 (USD MILLION)
TABLE 225. MEXICO DESFLURANE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 226. MEXICO DESFLURANE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 227. MEXICO DESFLURANE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 228. MEXICO DESFLURANE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 229. MEXICO DESFLURANE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 230. MEXICO DESFLURANE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 231. MEXICO DESFLURANE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 232. MEXICO DESFLURANE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 233. MEXICO DESFLURANE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 234. MEXICO DESFLURANE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 235. MEXICO DESFLURANE MARKET SIZE, BY CARDIOLOGY, 2018-2024 (USD MILLION)
TABLE 236. MEXICO DESFLURANE MARKET SIZE, BY CARDIOLOGY, 2025-2030 (USD MILLION)
TABLE 237. MEXICO DESFLURANE MARKET SIZE, BY GENERAL SURGERY, 2018-2024 (USD MILLION)
TABLE 238. MEXICO DESFLURANE MARKET SIZE, BY GENERAL SURGERY, 2025-2030 (USD MILLION)
TABLE 239. MEXICO DESFLURANE MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, 2018-2024 (USD MILLION)
TABLE 240. MEXICO DESFLURANE MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, 2025-2030 (USD MILLION)
TABLE 241. MEXICO DESFLURANE MARKET SIZE, BY ORTHOPEDICS, 2018-2024 (USD MILLION)
TABLE 242. MEXICO DESFLURANE MARKET SIZE, BY ORTHOPEDICS, 2025-2030 (USD MILLION)
TABLE 243. MEXICO DESFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 244. MEXICO DESFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 245. MEXICO DESFLURANE MARKET SIZE, BY DRUG WHOLESALERS, 2018-2024 (USD MILLION)
TABLE 246. MEXICO DESFLURANE MARKET SIZE, BY DRUG WHOLESALERS, 2025-2030 (USD MILLION)
TABLE 247. MEXICO DESFLURANE MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 248. MEXICO DESFLURANE MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 249. MEXICO DESFLURANE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 250. MEXICO DESFLURANE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 251. MEXICO DESFLURANE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 252. MEXICO DESFLURANE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 253. MEXICO DESFLURANE MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 254. MEXICO DESFLURANE MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 255. MEXICO DESFLURANE MARKET SIZE, BY MULTI DOSE VIALS, 2018-2024 (USD MILLION)
TABLE 256. MEXICO DESFLURANE MARKET SIZE, BY MULTI DOSE VIALS, 2025-2030 (USD MILLION)
TABLE 257. MEXICO DESFLURANE MARKET SIZE, BY SINGLE DOSE VIALS, 2018-2024 (USD MILLION)
TABLE 258. MEXICO DESFLURANE MARKET SIZE, BY SINGLE DOSE VIALS, 2025-2030 (USD MILLION)
TABLE 259. BRAZIL DESFLURANE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 260. BRAZIL DESFLURANE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 261. BRAZIL DESFLURANE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 262. BRAZIL DESFLURANE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 263. BRAZIL DESFLURANE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 264. BRAZIL DESFLURANE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 265. BRAZIL DESFLURANE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 266. BRAZIL DESFLURANE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 267. BRAZIL DESFLURANE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 268. BRAZIL DESFLURANE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 269. BRAZIL DESFLURANE MARKET SIZE, BY CARDIOLOGY, 2018-2024 (USD MILLION)
TABLE 270. BRAZIL DESFLURANE MARKET SIZE, BY CARDIOLOGY, 2025-2030 (USD MILLION)
TABLE 271. BRAZIL DESFLURANE MARKET SIZE, BY GENERAL SURGERY, 2018-2024 (USD MILLION)
TABLE 272. BRAZIL DESFLURANE MARKET SIZE, BY GENERAL SURGERY, 2025-2030 (USD MILLION)
TABLE 273. BRAZIL DESFLURANE MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, 2018-2024 (USD MILLION)
TABLE 274. BRAZIL DESFLURANE MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, 2025-2030 (USD MILLION)
TABLE 275. BRAZIL DESFLURANE MARKET SIZE, BY ORTHOPEDICS, 2018-2024 (USD MILLION)
TABLE 276. BRAZIL DESFLURANE MARKET SIZE, BY ORTHOPEDICS, 2025-2030 (USD MILLION)
TABLE 277. BRAZIL DESFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 278. BRAZIL DESFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 279. BRAZIL DESFLURANE MARKET SIZE, BY DRUG WHOLESALERS, 2018-2024 (USD MILLION)
TABLE 280. BRAZIL DESFLURANE MARKET SIZE, BY DRUG WHOLESALERS, 2025-2030 (USD MILLION)
TABLE 281. BRAZIL DESFLURANE MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 282. BRAZIL DESFLURANE MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 283. BRAZIL DESFLURANE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 284. BRAZIL DESFLURANE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 285. BRAZIL DESFLURANE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 286. BRAZIL DESFLURANE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 287. BRAZIL DESFLURANE MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 288. BRAZIL DESFLURANE MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 289. BRAZIL DESFLURANE MARKET SIZE, BY MULTI DOSE VIALS, 2018-2024 (USD MILLION)
TABLE 290. BRAZIL DESFLURANE MARKET SIZE, BY MULTI DOSE VIALS, 2025-2030 (USD MILLION)
TABLE 291. BRAZIL DESFLURANE MARKET SIZE, BY SINGLE DOSE VIALS, 2018-2024 (USD MILLION)
TABLE 292. BRAZIL DESFLURANE MARKET SIZE, BY SINGLE DOSE VIALS, 2025-2030 (USD MILLION)
TABLE 293. ARGENTINA DESFLURANE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 294. ARGENTINA DESFLURANE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 295. ARGENTINA DESFLURANE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 296. ARGENTINA DESFLURANE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 297. ARGENTINA DESFLURANE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 298. ARGENTINA DESFLURANE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 299. ARGENTINA DESFLURANE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 300. ARGENTINA DESFLURANE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 301. ARGENTINA DESFLURANE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 302. ARGENTINA DESFLURANE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 303. ARGENTINA DESFLURANE MARKET SIZE, BY CARDIOLOGY, 2018-2024 (USD MILLION)
TABLE 304. ARGENTINA DESFLURANE MARKET SIZE, BY CARDIOLOGY, 2025-2030 (USD MILLION)
TABLE 305. ARGENTINA DESFLURANE MARKET SIZE, BY GENERAL SURGERY, 2018-2024 (USD MILLION)
TABLE 306. ARGENTINA DESFLURANE MARKET SIZE, BY GENERAL SURGERY, 2025-2030 (USD MILLION)
TABLE 307. ARGENTINA DESFLURANE MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, 2018-2024 (USD MILLION)
TABLE 308. ARGENTINA DESFLURANE MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, 2025-2030 (USD MILLION)
TABLE 309. ARGENTINA DESFLURANE MARKET SIZE, BY ORTHOPEDICS, 2018-2024 (USD MILLION)
TABLE 310. ARGENTINA DESFLURANE MARKET SIZE, BY ORTHOPEDICS, 2025-2030 (USD MILLION)
TABLE 311. ARGENTINA DESFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 312. ARGENTINA DESFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 313. ARGENTINA DESFLURANE MARKET SIZE, BY DRUG WHOLESALERS, 2018-2024 (USD MILLION)
TABLE 314. ARGENTINA DESFLURANE MARKET SIZE, BY DRUG WHOLESALERS, 2025-2030 (USD MILLION)
TABLE 315. ARGENTINA DESFLURANE MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 316. ARGENTINA DESFLURANE MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 317. ARGENTINA DESFLURANE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 318. ARGENTINA DESFLURANE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 319. ARGENTINA DESFLURANE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 320. ARGENTINA DESFLURANE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 321. ARGENTINA DESFLURANE MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 322. ARGENTINA DESFLURANE MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 323. ARGENTINA DESFLURANE MARKET SIZE, BY MULTI DOSE VIALS, 2018-2024 (USD MILLION)
TABLE 324. ARGENTINA DESFLURANE MARKET SIZE, BY MULTI DOSE VIALS, 2025-2030 (USD MILLION)
TABLE 325. ARGENTINA DESFLURANE MARKET SIZE, BY SINGLE DOSE VIALS, 2018-2024 (USD MILLION)
TABLE 326. ARGENTINA DESFLURANE MARKET SIZE, BY SINGLE DOSE VIALS, 2025-2030 (USD MILLION)
TABLE 327. EUROPE, MIDDLE EAST & AFRICA DESFLURANE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 328. EUROPE, MIDDLE EAST & AFRICA DESFLURANE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 329. EUROPE, MIDDLE EAST & AFRICA DESFLURANE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 330. EUROPE, MIDDLE EAST & AFRICA DESFLURANE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 331. EUROPE, MIDDLE EAST & AFRICA DESFLURANE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 332. EUROPE, MIDDLE EAST & AFRICA DESFLURANE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 333. EUROPE, MIDDLE EAST & AFRICA DESFLURANE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 334. EUROPE, MIDDLE EAST & AFRICA DESFLURANE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 335. EUROPE, MIDDLE EAST & AFRICA DESFLURANE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 336. EUROPE, MIDDLE EAST & AFRICA DESFLURANE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 337. EUROPE, MIDDLE EAST & AFRICA DESFLURANE MARKET SIZE, BY CARDIOLOGY, 2018-2024 (USD MILLION)
TABLE 338. EUROPE, MIDDLE EAST & AFRICA DESFLURANE MARKET SIZE, BY CARDIOLOGY, 2025-2030 (USD MILLION)
TABLE 339. EUROPE, MIDDLE EAST & AFRICA DESFLURANE MARKET SIZE, BY GENERAL SURGERY, 2018-2024 (USD MILLION)
TABLE 340. EUROPE, MIDDLE EAST & AFRICA DESFLURANE MARKET SIZE, BY GENERAL SURGERY, 2025-2030 (USD MILLION)
TABLE 341. EUROPE, MIDDLE EAST & AFRICA DESFLURANE MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, 2018-2024 (USD MILLION)
TABLE 342. EUROPE, MIDDLE EAST & AFRICA DESFLURANE MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, 2025-2030 (USD MILLION)
TABLE 343. EUROPE, MIDDLE EAST & AFRICA DESFLURANE MARKET SIZE, BY ORTHOPEDICS, 2018-2024 (USD MILLION)
TABLE 344. EUROPE, MIDDLE EAST & AFRICA DESFLURANE MARKET SIZE, BY ORTHOPEDICS, 2025-2030 (USD MILLION)
TABLE 345. EUROPE, MIDDLE EAST & AFRICA DESFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 346. EUROPE, MIDDLE EAST & AFRICA DESFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 347. EUROPE, MIDDLE EAST & AFRICA DESFLURANE MARKET SIZE, BY DRUG WHOLESALERS, 2018-2024 (USD MILLION)
TABLE 348. EUROPE, MIDDLE EAST & AFRICA DESFLURANE MARKET SIZE, BY DRUG WHOLESALERS, 2025-2030 (USD MILLION)
TABLE 349. EUROPE, MIDDLE EAST & AFRICA DESFLURANE MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 350. EUROPE, MIDDLE EAST & AFRICA DESFLURANE MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 351. EUROPE, MIDDLE EAST & AFRICA DESFLURANE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 352. EUROPE, MIDDLE EAST & AFRICA DESFLURANE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 353. EUROPE, MIDDLE EAST & AFRICA DESFLURANE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 354. EUROPE, MIDDLE EAST & AFRICA DESFLURANE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 355. EUROPE, MIDDLE EAST & AFRICA DESFLURANE MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 356. EUROPE, MIDDLE EAST & AFRICA DESFLURANE MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 357. EUROPE, MIDDLE EAST & AFRICA DESFLURANE MARKET SIZE, BY MULTI DOSE VIALS, 2018-2024 (USD MILLION)
TABLE 358. EUROPE, MIDDLE EAST & AFRICA DESFLURANE MARKET SIZE, BY MULTI DOSE VIALS, 2025-2030 (USD MILLION)
TABLE 359. EUROPE, MIDDLE EAST & AFRICA DESFLURANE MARKET SIZE, BY SINGLE DOSE VIALS, 2018-2024 (USD MILLION)
TABLE 360. EUROPE, MIDDLE EAST & AFRICA DESFLURANE MARKET SIZE, BY SINGLE DOSE VIALS, 2025-2030 (USD MILLION)
TABLE 361. EUROPE

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Desflurane market report include:
  • Baxter International, Inc.
  • Fresenius Kabi AG
  • Piramal Enterprises Limited
  • Hikma Pharmaceuticals PLC
  • Aspen Pharmacare Holdings Limited
  • Halocarbon Products Corporation
  • Jiangsu Nhwa Pharmaceutical Co., Ltd.
  • Shanghai Hengrui Pharmaceutical Co., Ltd.
  • Guangzhou Freda Pharmaceutical Co., Ltd.
  • Sichuan Kelun Pharmaceutical Co., Ltd.

Related Topics

Related Reports

Halogenated Hydrocarbon General Anesthetics Market by Agent Type (Desflurane, Enflurane, Halothane), End User (Ambulatory Surgical Center, Hospital, Office Based Anesthesia), Application, Distribution Channel, Formulation - Global Forecast 2025-2030 - Product Image

Halogenated Hydrocarbon General Anesthetics Market by Agent Type (Desflurane, Enflurane, Halothane), End User (Ambulatory Surgical Center, Hospital, Office Based Anesthesia), Application, Distribution Channel, Formulation - Global Forecast 2025-2030

  • Report
  • 198 Pages
  • Global
From
Inhalation Anesthetics - Global Strategic Business Report - Product Image

Inhalation Anesthetics - Global Strategic Business Report

  • Report
  • 194 Pages
  • Global
From
Isoflurane and Desflurane Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type - Product Image

Isoflurane and Desflurane Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type

  • Report
  • 71 Pages
  • Global
From
Desflurane (CAS 57041-67-5) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Desflurane (CAS 57041-67-5) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
U.S. Inhalation Anesthesia Market Size, Share & Trends Analysis Report by Drug (Sevoflurane, Desflurane), Application (Induction, Maintenance), End-use (Hospitals, ASC) with Growth Forecasts, 2025-2030 - Product Image

U.S. Inhalation Anesthesia Market Size, Share & Trends Analysis Report by Drug (Sevoflurane, Desflurane), Application (Induction, Maintenance), End-use (Hospitals, ASC) with Growth Forecasts, 2025-2030

  • Report
  • 80 Pages
  • United States
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.